Women with Parkinson’s may be more vulnerable to Alzheimer’s pathology
Women with Parkinson’s disease may be more vulnerable to Alzheimer’s-related changes in the brain than men, according to…
What we know about the Alzheimer’s drug Health Canada approved
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer’s disease, raising questions about its effectiveness…